Next Article in Journal
Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi
Next Article in Special Issue
Incidence and Associated Factors of SARS-CoV-2 Infection Post-mRNA-1273 Booster Vaccination in Health-Care Workers
Previous Article in Journal
Seasonal Variation and Geographical Distribution of COVID-19 across Nigeria (March 2020–July 2021)
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Vaccines
Volume 11
Issue 2
10.3390/vaccines11020296
vaccines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Predicting Intention to Receive COVID-19 Vaccination in People Living with HIV using an Integrated Behavior Model

by
Bramantya Wicaksana
1,
Evy Yunihastuti
2,*,
Hamzah Shatri
1,
Dicky C. Pelupessy
3,
Sukamto Koesnoe
2,
Samsuridjal Djauzi
4,
Haridana Indah Setiawati Mahdi
4,
Dyah Agustina Waluyo
5,
Zubairi Djoerban
5 and
Tommy Hariman Siddiq
6
1
Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia—Cipto Mangunkusumo Hospital, Jakarta 10430, Indonesia
2
Allergy and Clinical Immunology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo Hospital, Jakarta 10430, Indonesia
3
Faculty of Psychology, Universitas Indonesia, Depok 16424, Indonesia
4
Department of Non-Oncology Internal Medicine, Dharmais National Cancer Hospital, Jakarta 11420, Indonesia
5
Kramat 128 Hospital, Jakarta 10430, Indonesia
6
Faculty of Psychology and Education, Universitas Al Azhar Indonesia, Jakarta 12110, Indonesia
*
Author to whom correspondence should be addressed.
Vaccines 2023, 11(2), 296; https://doi.org/10.3390/vaccines11020296
Submission received: 7 December 2022 / Revised: 25 January 2023 / Accepted: 25 January 2023 / Published: 29 January 2023
(This article belongs to the Special Issue COVID-19 and Vaccination Strategies in Global Health)
Browse Figure
Review Reports Versions Notes

Abstract

:
People living with HIV (PLHIV) are considered a high-risk population for developing a severe form of COVID-19. Vaccination is still one of the most important modalities in combating the disease due to the lack of an effective treatment. This multicenter study was performed from September to December 2021 with the aim to analyze the intention of PLHIV to receive the COVID-19 vaccination based on an integrated behavior model (IBM) in Indonesia. Of a total of 470 participants, 75.6% of patients were intent to be vaccinated. The model that was designed in this study explains 43.4% of the variance in intention to be vaccinated against COVID-19 in PLHIV (adjusted R2 = 0.434). Furthermore, the determinants used included instrumental attitude (β = 0.127, p < 0.05), subjective norm (β = 0.497, p < 0.01), and perceived behavioral control (β = 0.116, p < 0.01). This study concluded that an IBM could predict the intention of PLHIV to receive COVID-19 vaccination.

1. Introduction

The coronavirus disease of 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV−2). This disease remains a global public health problem that has affected over 610 million people and resulted in over 6.5 million deaths globally [1]. From the beginning of pandemic to November 2022, 145 thousand deaths due to COVID-19 were reported in Indonesia [2]. Despite most cases of COVID-19 being clinically mild or asymptomatic, older patients and those with multiple comorbidities have an increased risk of severe disease and death [3,4].
Efforts to minimize the incidence and severity of COVID-19 are mainly through vaccination due to the lack of an effective curative treatment [5,6]. Despite the remarkable production of vaccines and unprecedented heights reached in research and manufacturing speed, the worldwide threat of this virus is far from ending, especially for high-risk groups. According to the most recent Global COVID Access Tracker data, approximately one-quarter of the world’s most vulnerable populations still require a primary vaccination series against COVID-19 [7].
People with comorbidities are classified as vulnerable, while people living with HIV (PLHIV) are considered to be at high risk of developing COVID-19 infection due to their impaired immunity. PLHIV with immune suppression, unsuppressed HIV RNA viral load, or comorbidities are at increased risk of severe disease and death from COVID-19 infection [4,8]. A recent meta-analysis reported that PLHIV have 1.3- and 2.3-fold increased risks of severe disease and death, respectively, compared to patients without HIV infection [4]. Another meta-analysis also indicated that HIV is associated with a 1.8-fold increased risk of death due to COVID-19 infection [9].
Research on COVID-19 vaccine acceptance and intention among PLHIV has been conducted in several countries. The results of these studies have shown that there is still apprehension and hesitancy in this population [10,11,12]. One of the many reasons behind the reluctance of PLHIV has been restricted access to vaccination [13]. At the beginning of the COVID-19 vaccination program in Indonesia, the required pre-vaccine evaluation form contained a question about HIV status [14,15]. This question may have induced hesitation among PLHIV to receive vaccination. Therefore, this study recognizes that it is essential to further examine the beliefs of PLHIV about COVID-19 vaccination and develop strategies to encourage its uptake [16].
The use of theoretical behavior models can be valuable in predicting intention to be vaccinated and for understanding the determinants of acceptance or hesitancy [17]. The integrated behavior model (IBM) is a framework for understanding and influencing human behavior centered on intention [18]. Theoretical behavior models have been widely used to determine the intention of COVID-19 vaccination in the general population, medical and nursing students, and healthcare workers [5,17,19,20].
By analyzing the behavior of a population, it should be possible to determine the most likely significant IBM components that play a role in intention to receive a COVID-19 vaccination. However, there are still limited studies on the intention of PLHIV, and none of these studies used an IBM approach. Therefore, this study aimed to analyze the attitudes and beliefs of PLHIV with regards to COVID-19 vaccination and identify the determinants influencing the decision to be vaccinated using an IBM framework.

2. Materials and Methods

2.1. Theoretical Framework

Montaño and colleagues developed the IBM by combining the theory of reasoned action (TRA), the theory of planned behavior (TPB), and other notable behavioral theories. The IBM incorporates the TRA, TPB, the health belief model (HBM), and social cognitive theory [21]. The model’s fundamental construct is behavior, which is defined as a single observable action performed by an individual. The intention to conduct the behavior, as in the TRA/TPB, is the essential driver of behavior. Thus, there should be a high degree of consistency between intention and behavior. According to the paradigm, three theoretical factors (attitude, perceived norm, and personal agency) primarily influence behavioral intention [21,22,23].

2.2. Study Design

This was a cross-sectional study conducted from September to December 2021 using a paper-based survey and an online survey. The subjects were PLHIV of at least 18 years of age who had consented to the questionnaires and were able to complete them. The participants were recruited from the outpatient clinics of three HIV centers in Jakarta: Cipto Mangunkusumo Hospital, Dharmais National Cancer Hospital, and Kramat 128 Hospital.
The study was conducted in two phases, (1) a qualitative research-elicitation phase to identify COVID-19 vaccination concerns among a representative sample of PLHIV in the study sites, and (2) a cross-sectional quantitative survey. First, individual qualitative interviews were conducted with nine PLHIV in the Indonesian language with questions structured around IBM components. The subjects were asked to consider receiving COVID-19 vaccination, and then report their sentiments and views regarding the outcomes and sources of normative influence, as well as the challenges and facilitators of vaccination. Consent analysis of the transcribed interviews presented their sentiments, sources of normative influence towards vaccination, obstacles, and facilitators of vaccination. Finally, a content analysis was performed for ten instrumental attitudes, five experiential attitudes, six subjective norms, three self-efficacies, and three perceived behavioral control statements.

2.3. Survey Instrument

Each item of the IBM instrument was assessed using a 7-point bipolar scale. Behavioral intentions were measured using three items related to PLHIV intention to receive COVID-19 vaccination. These included “I hope to be able to be vaccinated against COVID-19 when the schedule is available”, “I want to be vaccinated against COVID-19 with the currently available vaccine”, and “I will continue to be vaccinated against COVID-19 even though there are obstacles to doing so.” Participants responded using a scale of strongly disagree (1) to strongly agree (7). The final result was the mean score of the three items. The mean score was then used to define intention. Values above 5 on this scale of 1 to 7 were classified as “intent to receive vaccination,” a value of 4 was classified as “undecided or neutral,” and below 3 was classified “not intent to receive vaccination.”
The ten instrumental and five experiential attitude statements were multiplied by a comparable item evaluating each sentence to measure attitude toward COVID-19 vaccination. The multiplicative scores for all items were added together. Six subjective norm statements were multiplied by a motivation score to comply with each statement to determine the subjective norm. Self-efficacy and perceived behavioral control were measured by multiplying each belief by a perceived power item. Since injunctive norms were not presented during the elicitation phase, this construct was not investigated.
In addition, data on age, gender, marital status, education status, occupation, antiretroviral therapy (ART) consumption, recent absolute cluster differentiation 4 (CD4) count, HIV risk factors, history of COVID-19 infection, first COVID-19 vaccination status, and history of vaccination other than COVID-19 were collected.

2.4. Recruitment

The eligible patients from the outpatient clinics were selected using simple random sampling, which was automatically generated using random.org. The chosen participants then received information about the study objectives and procedure and completed an informed consent, either written or electronic according to their preference. If a selected patient refused to give consent or had been recruited in the previous visit, we shifted recruitment to the next selected patient in line.
The consent form included a disclaimer stating that participation was voluntary and refusal to participate had no implication. This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Faculty of Medicine, Universitas Indonesia.

2.5. Data Analysis

Data were analyzed using SPSS® Statistics 25 for Windows software (IBM Corp., Armonk, New York, USA). Descriptive analyses were conducted on background or sociodemographic factors and HIV characteristics. The calculated mean and standard deviation are presented for continuous variables, and categorical variables are presented as numbers and percentages. Syntax was used for common data transformation [24] to account for non-normality within the linear model framework and ensure statistical conclusion validity. The results of the evaluation of assumptions led to the transformation of the variables to reduce skewness and the number of outliers, as well as improve the normality, linearity, and homoscedasticity of residuals.
Analyses were conducted to identify the specific beliefs underlying the IBM constructs that best explained COVID-19 vaccination intention. The enter method was used to run hierarchical multiple regression on each IBM component linked with intention. Finally, statistical significance was evaluated at the p < 0.05 level. The correlation between level of intention and status of the first COVID-19 vaccination was also analyzed using the Kendall Tau-B method.

3. Results

3.1. Background Characteristics

A total of 4538 PLHIV were recruited during their clinic visits. After random sampling, 775 were invited to join the study. Due to time constraints, 295 PLHIV were unwilling to participate. The number of participants who completed the questionnaires at each study site were 204, 211, and 65 from Cipto Mangunkusumo Hospital, Dharmais National Cancer Hospital, and Kramat 128 Hospital, respectively. A total of 456 out of 480 participants primarily opted for paper-based questionnaires; however, 10 of these participants submitted incomplete IBM questionnaire data. As a result, 470 participants were included in the analysis, as shown in Figure 1.
Most participants were men (76.2%) with a median age of 41 years old (IQR = 19, range 18−76 years old). Seventy percent of participants had recent CD4 counts of more than 200 cells/mm3. The majority of participants were on antiretroviral therapy (96.4%), with a median duration of nine years (IQR = 7). Eighty-three participants (17.7%) had previously contracted COVID-19. The participants’ demographic, socioeconomic, and other clinical characteristics are summarized in Table 1.

3.2. Intention

The intention of PLHIV to be vaccinated against COVID-19 was found to be quite satisfactory, as 75.6% of participants had intention to receive vaccination, 20.6% were unsure or neutral, and 3.8% had no intention to receive vaccination. Cross-tabulation between intention to receive COVID-19 and the actual behavior of receiving the first COVID-19 vaccination exhibited a moderate association (Kendall’s tau-b = 0.226, p < 0.01). This indicates that there is a link between the intention of PLHIV to receive COVID-19 vaccination and their actual behavior in receiving it.

3.3. IBM Constructs

Based on the internal consistency analysis and correlation with the cut-off value of 0.30, items that construct instrumental attitude, experiential attitude, subjective norm, self-efficacy, and perceived behavioral control exhibited positive correlation results with Cronbach’s alpha with values of 0.910, 0.768, 0.918, 0.652, and 0.714, respectively. Two items in instrumental attitude, one in experiential attitude, and one in perceived behavioral control were eliminated. Table 2 demonstrates the internal consistency and correlation between each item and the independent variable.

3.4. Final Regression Model

The final regression model included all constructs of the IBM. Data on subjective norms and perceived behavioral control were normally distributed, but data on instrumental attitude, experiential attitude, self-efficacy, and intention were not. There were no cases of missing data.
Table 3 displays the correlation between the variables, the unstandardized (B) and standardized regression coefficients (β), R, and R2 for the model analyzing COVID-19 vaccination intention. In the model, IBM items and intention were analyzed. It explained 43.4% of the variance in the intention of PLHIV to receive COVID-19 vaccination (adjusted R2 = 0.434). R for regression was significantly different from zero, F(5, 470) = 69.437, p < 0.001.
The significant predictors of intention to receive COVID-19 vaccination in the model were instrumental attitude (p < 0.05), subjective norm (p < 0.01), and perceived behavior control (p < 0.01). In the model, these constructs were considered positive predictors of intention.
In instrumental attitude, the phrase “Getting the COVID-19 vaccination will reduce the severity of SARS-CoV−2 infection once I get infected.” had a significant effect (β = 0.199, p = 0.001). Further analysis of the subjective norms indicated that government program (β = 0.15, p = 0.002), doctors (β = 0.81, p = 0.011), religious leaders (β = 0.15, p = 0.012), and family (β = 0.202, p = 0.001) were all considerable factors in the intention of receiving COVID-19 vaccination. The results of multiple linear regression revealed that both items of the perceived behavioral control construct were significant items in the model: “How often have you been in a situation that made it easy for you to achieve what you wanted?” (β = 0.11, p = 0.036) and “How often does the belief ‘I can do it’ dominate your daily life?” (β = 0.36, p < 0.01). Further details of the IBM components are attached in Supplementary Table S1.

4. Discussion

This is the first Indonesian study on PLHIV intention to receive vaccination against COVID-19. This multicenter study used a simple random sampling method to select representatives of the population and participants were allowed to respond using an online or an offline method. The population in this study was made up of relatively technology-illiterate people, who are underrepresented in many surveys. Most of the study participants (95%) preferred using paper-based questionnaires. In addition, this is the first study to use the IBM approach in PLHIV, which is the latest method of predicting intention to receive COVID-19 vaccination. However, 38% of patients initially selected refused to participate, primarily due to a lack of time during clinic visits. Many PLHIV only spend a short amount of time in the clinic for their routine ART visits.
Most of the participants (75.6%) had the intention to receive COVID-19 vaccination. This finding is higher than a study conducted in 2021 in eight major cities in China, where only 57.2% of patients were willing to be vaccinated [10]. This number is also higher than the report from a study in the Middle East and North Africa between March and August 2021, which stated a vaccine acceptance rate of 64.6% among PLHIV [25]. The current study started in September 2021, several months after the initiation of the COVID-19 vaccination program for the general population in Indonesia. Therefore, hesitancy regarding its use in the PLHIV population and misinformation about the vaccines were still high. The vaccine recommendation in Indonesia initially comprised a question regarding HIV status in its screening form, including the respondent’s latest CD4 level [14,15]. This may have made many PLHIV uncertain about receiving the vaccination, not only because they would need to disclose their HIV status in the vaccine center, but also because it may have made them question their eligibility to get the vaccination.
Previous studies have reported that vaccination intention was lower in PLHIV compared to the non-HIV population [12]. To the authors’ knowledge, there is no study in Indonesia comparing the COVID-19 vaccination intention of PLHIV to that of non-PLHIV. However, our previous study found that PLHIV do have an understanding that they are more susceptible to COVID-19 infection. [26] A recent study reported that mortality and severity of COVID-19 were higher in PLHIV with lower CD4 counts [27]. In the current study, most patients had high CD4 counts. Nevertheless, the participants appeared to have a high sense of perceived risk of severe COVID-19 infection. This was shown by the significant level of acceptance that receiving the vaccination would reduce the severity of COVID-19 infection.
In our final model, instrumental attitude, perceived behavioral control, and subjective norms were the three constructs of IBM that predicted 43% PLHIV intention to receive the COVID-19 vaccination. Instrumental attitude is defined as a person’s overall favorableness or unfavorableness toward performing a behavior based on the cognitive dimension [21]. “Getting the COVID-19 vaccination will reduce the severity of SARS-CoV−2 infection once I get infected” was the only statement in the instrumental attitude construct that affected intention (β 0.645, p < 0.01). This finding correlates to a study in Italy, which found that PLHIV believed that their condition was associated with a higher risk of developing complications of COVID-19 infection (p = 0.013) [28]. A previous study in Indonesia using the health belief model on the general population also demonstrated a similar association between vaccination willingness and the perceived benefits of COVID-19 vaccination [29].
Ajzen et al. [21,30] added perceived behavioral control in the TPB model. This was performed to account for the reasoning that a person’s perception of control over behavioral performance, together with intention, is expected to directly affect behavior, mainly when volitional control is not high. Among PLHIV, volitional control over the choice of COVID-19 vaccination indicated by the PBC items appeared to be a significant predictor in this current study. The earliest COVID-19 vaccination recommendation released by the Ministry of Health and The Indonesian Society of Internal Medicine back in 2020 suggested against vaccinating PLHIV with a low CD4 count. It is possible that this led to PLHIV experiencing difficulties receiving a vaccination as vaccination centers likely suspended vaccines for PLHIV with unknown recent CD4 counts. This recommendation was cancelled in December 2020; however, it appears that it still causes confusion and apprehension for many healthcare workers [15].
It is interesting to note that the participants to this study still considered their loved ones’ advice when making the decision to receive a COVID-19 vaccination. This subjective norm was the most significant construct in the IBM framework related to vaccination intention (β = 0.497, Table S1). The most important item of the subjective norms was found to be “My family expects me to receive the COVID-19 vaccination”. Government initiatives, advice from religious leaders, and suggestions from their doctors followed in the three next highest positions. This outcome shows very clearly how important it is to educate the patients and their families. The importance of clear and transparent information, particularly from the relevant authorities, is emphasized in this study.
This study has some limitations. First, about one-third of the selected PLHIV refused to participate in the study. Some of the reasons for this non-response error in survey were a lack of time, a lack of motivation, and fear of being registered as a HIV positive person. In terms of time, in all three centers, most PLHIV only plan to spend a short amount of time at the clinic for their routine ART visit. In addition, unvaccinated PLHIV might have a negative attitude towards vaccination, making them more likely to refuse to participate in the study. The study found a moderate correlation between intention to receive a vaccination and the actual action of getting the first COVID-19 vaccination. We could not find any study that indicated a direct association between intention and the actual behavior in receiving vaccination. Jaiswal et al., in fact, demonstrated a negative association between the COVID-19 vaccine hesitancy score and the intention to be vaccinated. COVID-19 vaccine hesitancy score was also negatively associated with COVID-19 vaccine uptake in PLHIV. COVID-19 vaccine hesitancy score also had a negative association with the intention to be vaccinated [31].
A second limitation is that our study was performed during the initial stages of the COVID-19 vaccination in the general population. Therefore, the questionnaire only asked about the first COVID-19 vaccination uptake. We do not have data regarding their actual behavior toward receiving the second or third COVID-19 vaccination. It is important to continuously analyze intention and actual vaccine uptake among PLHIV in line with developments in the pandemic situation. This is because uptake is highly correlated with vaccine safety, benefits, and real-life circumstances of the pandemic. However, we can use this IBM model to create a more focused approach to encourage the next COVID-19 vaccination or other new vaccines in the future.
The results of this current study could help policymakers and related institutions to form better recommendations and policies for COVID-19 vaccination in PLHIV. First and foremost, there needs to be focus on the benefit of the COVID-19 vaccination for PLHIV, particularly the reduction of the severity of SARS-CoV−2 infection. Second, PLHIV in this study had low perceived behavioral control; thus, they need external support to ensure a firm intention to receive COVID-19 vaccination. Aside from the government’s national program, endorsement from religious leaders and their HIV physicians is essential for this population. Involving family members in education regarding COVID-19 vaccination is also needed. In addition, providing PLHIV with relevant and evidence-based information would help strengthen their intention.

5. Conclusions

This study has demonstrated the IBM model’s feasibility for the prediction of the intention of PLHIV to a receive COVID-19 vaccination. Among the components of the IBM, instrumental attitude, subjective norms, and perceived behavioral control were significantly correlated with vaccination intention. The most critical factor was the subjective norms. Therefore, the concerns of PLHIV should be put at ease by a profusion of relevant and evidence-based recommendations about vaccine benefits and safety.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/vaccines11020296/s1, Table S1: Analysis on items of each IBM component.

Author Contributions

B.W., E.Y., H.S., D.C.P. and S.K. initiated and designed the study. B.W., D.C.P. and E.Y. developed the survey tool. B.W. led and distributed the survey with E.Y., S.K., S.D., H.I.S.M., D.A.W. and Z.D. B.W., T.H.S. and S.K. performed the statistical analysis. B.W. and E.Y. prepared the first draft of the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This study was funded by PUTI grant awarded Universitas Indonesia number: NKB-158/UN2.RST/HKP.05.00/2022.

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Faculty of Medicine Universitas Indonesia Cipto Mangunkusumo Hospital (No: KET−536/UN2.F1/ETIK/PPM.00.02/2021).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study. The consent form included a disclaimer stating that participation was voluntary, and no penalties were involved for refusing to participate.

Data Availability Statement

All data in the manuscript can be obtained with reasonable request from the corresponding author.

Acknowledgments

We would like to thank all patients who took part in the study. We would also like to thank Ghina Shabrina Awanis, Salma Sundari, Tikadhani, Tika Surya Atmaja, Andrian Wiraguna, Veritea Natali, and Fatih Anfasa for their help in this study.

Conflicts of Interest

The authors declare that they have no competing interest.

References

  1. WHO. Coronavirus (COVID-19) Dashboard. 2022. Available online: https://covid19.who.int (accessed on 25 September 2022).
  2. COVID-19 Task Force. Peta Sebaran (COVID-19 Distribution Map). 2022. Available online: https://covid19.go.id/en/peta-sebaran (accessed on 6 October 2022).
  3. Dong, Y.; Li, Z.; Ding, S.; Liu, S.; Tang, Z.; Jia, L.; Liu, J.; Liu, Y. HIV Infection and Risk of COVID-19 Mortality: A Meta-Analysis. Medicine 2021, 100, e26573. [Google Scholar] [CrossRef] [PubMed]
  4. Oyelade, T.; Alqahtani, J.S.; Hjazi, A.M.; Li, A.; Kamila, A.; Raya, R.p. Global and Regional Prevalence and Outcomes of COVID-19 in People Living with HIV: A Systematic Review and Meta-Analysis. Trop Med. Infect. Dis 2022, 7, 22. [Google Scholar] [CrossRef] [PubMed]
  5. Koesnoe, S.; Siddiq, T.H.; Pelupessy, D.C.; Yunihastuti, E.; Awanis, G.S.; Widhani, A.; Karjadi, T.H.; Maria, S.; Hasibuan, A.S.; Rengganis, I.; et al. Using Integrative Behavior Model to Predict COVID-19 Vaccination Intention among Health Care Workers in Indonesia: A Nationwide Survey. Vaccines 2022, 10, 719. [Google Scholar] [CrossRef] [PubMed]
  6. Arifin, B.; Anas, T. Lessons Learned from COVID-19 Vaccination in Indonesia: Experiences, Challenges, and Opportunities. Hum. Vaccines Immunother. 2021, 17, 3898–3906. [Google Scholar] [CrossRef] [PubMed]
  7. Global COVID-19 Access Tracker Global. COVID-19 Access Tracker. 2022. Available online: https://www.covid19globaltracker.org/ (accessed on 6 October 2022).
  8. Hariyanto, T.I.; Rosalind, J.; Christian, K.; Kurniawan, A. Human Immunodeficiency Virus and Mortality from Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. South. Afr J. HIV Med. 2021, 22, 1220. [Google Scholar] [CrossRef] [PubMed]
  9. Danwang, C.; Noubiap, J.J.; Robert, A.; Yombi, J.C. Outcomes of Patients with HIV and COVID-19 Co-Infection: A Systematic Review and Meta-Analysis. AIDS Res. Ther. 2022, 19, 3. [Google Scholar] [CrossRef]
  10. Huang, X.; Yu, M.; Fu, G.; Lan, G.; Li, L.; Yang, J.; Qiao, Y.; Zhao, J.; Qian, H.-Z.; Zhang, X.; et al. Willingness to Receive COVID-19 Vaccination Among People Living with HIV and AIDS in China: Nationwide Cross-Sectional Online Survey. JMIR Public Health Surveill 2021, 7, e31125. [Google Scholar] [CrossRef]
  11. Davtyan, M.; Frederick, T.; Taylor, J.; Christensen, C.; Brown, B.J.; Nguyen, A.L. Determinants of COVID-19 Vaccine Acceptability among Older Adults Living with HIV. Medicine 2022, 101, e29907. [Google Scholar] [CrossRef]
  12. Kaida, A.; Brotto, L.A.; Murray, M.C.M.; Côté, H.C.F.; Albert, A.Y.; Nicholson, V.; Gormley, R.; Gordon, S.; Booth, A.; Smith, L.W.; et al. Intention to Receive a COVID-19 Vaccine by HIV Status Among a Population-Based Sample of Women and Gender Diverse Individuals in British Columbia, Canada. AIDS Behav. 2022, 26, 2242–2255. [Google Scholar] [CrossRef]
  13. Shrestha, R.; Meyer, J.P.; Shenoi, S.; Khati, A.; Altice, F.L.; Mistler, C.; Aoun-Barakat, L.; Virata, M.; Olivares, M.; Wickersham, J.A. COVID-19 Vaccine Hesitancy and Associated Factors among People with HIV in the United States: Findings from a National Survey. Vaccines 2022, 10, 424. [Google Scholar] [CrossRef]
  14. PB PAPDI (Indonesian Society of Internal Medicine). Rekomendasi PAPDI Tentang Pemberian Vaksinasi COVID-19 (Sinovac/Inactivated) Pada Pasien dengan Penyakit Penyerta/ Komorbid (PAPDI’s Recommendation on Giving COVID-19 Vaccination (Sinovac/Inactivated) to Patients with Comorbidities). 2020. Available online: https://rsud.magelangkab.go.id/download/file/Rekomendasi%20PAPDI%20Tentang%20Pemberian%20Vaksinasi%20COVID19%20SinovacInactivated%20pada%20Pasien%20dengan%20Penyakit%20Penyerta%20Komorbid.pdf (accessed on 6 October 2022).
  15. PB PAPDI (Indonesian Society of Internal Medicine). Rekomendasi PAPDI Tentang Pemberian Vaksinasi COVID-19 (Sinovac/Inactivated) Pada Pasien Dengan Penyakit Penyerta/ Komorbid (PAPDI’s Recommendation on Giving COVID-19 Vaccination (Sinovac/Inactivated) to Patients with Comorbidities) Revision 2021. 9 February 2021. Available online: https://www.papdi.or.id/berita/info-papdi/1009-rekomendasi-papdi-tentang-pemberian-vaksinasi-covid-19 (accessed on 6 October 2022).
  16. Parimi, K.; Gilkeson, K.; Creamer, B.A. COVID-19 Vaccine Hesitancy: Considerations for Reluctance and Improving Vaccine Uptake. Hum. Vaccin. Immunother. 2022, 18, 2062972. [Google Scholar] [CrossRef] [PubMed]
  17. Rosental, H.; Shmueli, L. Integrating Health Behavior Theories to Predict COVID-19 Vaccine Acceptance: Differences between Medical Students and Nursing Students. Vaccines 2021, 9, 783. [Google Scholar] [CrossRef] [PubMed]
  18. Montaño, D.E.; Kasprzyk, D.; Hamilton, D.T.; Tshimanga, M.; Gorn, G. Evidence-Based Identification of Key Beliefs Explaining Adult Male Circumcision Motivation in Zimbabwe: Targets for Behavior Change Messaging. AIDS Behav. 2014, 18, 885–904. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Chu, H.; Liu, S. Integrating Health Behavior Theories to Predict American’s Intention to Receive a COVID-19 Vaccine. Patient Educ. Couns. 2021, 104, 1878–1886. [Google Scholar] [CrossRef] [PubMed]
  20. Shmueli, L. Predicting Intention to Receive COVID-19 Vaccine among the General Population Using the Health Belief Model and the Theory of Planned Behavior Model. BMC Public Health 2021, 21, 804. [Google Scholar] [CrossRef] [PubMed]
  21. Fishbein, M.; Ajzen, I. Predicting and Changing Behavior: The Reasoned Action Approach; Psychology Press: New York, NY, USA, 2010; ISBN 978-0-203-83802-0. [Google Scholar]
  22. Glanz, K.; Rimer, B.K.; Viswanath, K. Health Behavior: Theory, Research, and Practice, 5th ed.; Jossey-Bass/Wiley: San Francisco, CA, USA, 2015; ISBN 978-1-118-62898-0. [Google Scholar]
  23. Sharma, M.; Romas, J.A. Theoretical Foundations of Health Education and Health Promotion; Jones & Bartlett Learning: Burlington, MA, USA, 2012; ISBN 978-0-7637-9611-2. [Google Scholar]
  24. Tabachnick, B.G.; Fidell, L.S. Using Multivariate Statistics; Pearson: Boston, MA, USA, 2018; ISBN 978-0-13-479054-1. [Google Scholar]
  25. Mohamed, R.; White, T.M.; Lazarus, J.V.; Salem, A.; Kaki, R.; Marrakchi, W.; Kheir, S.G.M.; Amer, I.; Ahmed, F.M.; Khayat, M.A.; et al. COVID-19 Vaccine Acceptance and Associated Factors among People Living with HIV in the Middle East and North Africa Region. S. Afr. J. HIV Med. 2022, 23, 1391. [Google Scholar] [CrossRef]
  26. Karjadi, T.H.; Maria, S.; Yunihastuti, E.; Widhani, A.; Kurniati, N.; Imran, D. Knowledge, Attitude, Behavior, and Socioeconomic Conditions of People Living with HIV in Indonesia during the COVID-19 Pandemic: A Cross-Sectional Study. HIV AIDS 2021, 13, 1045–1054. [Google Scholar] [CrossRef]
  27. Yunihastuti, E.; Karjadi, T.H.; Widhani, A.; Mahdi, H.I.S.; Sundari, S.; Hapsari, A.F.; Koesnoe, S.; Djauzi, S. Incidence and Severity Prediction Score of COVID-19 in People Living with HIV (SCOVHIV): Experience from the First and Second Waves of the Pandemic in Indonesia. AIDS Res. Ther. 2022, 19, 47. [Google Scholar] [CrossRef]
  28. Bert, F.; Pivi, A.; Russotto, A.; Mollero, B.; Voglino, G.; Orofino, G.; Siliquini, R. COVID-19 Vaccination among HIV+ Patients: An Italian Cross-Sectional Survey. Vaccines 2022, 10, 1438. [Google Scholar] [CrossRef]
  29. Hidayana, I.; Amir, S.; Pelupessy, D.C.; Rahvenia, Z. Using a Health Belief Model to Assess COVID-19 Vaccine Intention and Hesitancy in Jakarta, Indonesia. PLOS Glob. Public Health 2022, 2. [Google Scholar] [CrossRef]
  30. Ajzen, I. The Theory of Planned Behavior. Organ. Behav. Hum. Decis. Process. 1991, 50, 179–211. [Google Scholar] [CrossRef]
  31. Jaiswal, J.; Krause, K.D.; Martino, R.J.; D’Avanzo, P.A.; Griffin, M.; Stults, C.B.; Karr, A.G.; Halkitis, P.N. SARS-CoV-2 Vaccination Hesitancy and Behaviors in a National Sample of People Living with HIV. AIDS Patient Care STDs 2022, 36, 34–44. [Google Scholar] [CrossRef] [PubMed]
Vaccines 11 00296 g001 550
Figure 1. Flowchart of data collection.
Figure 1. Flowchart of data collection.
Vaccines 11 00296 g001
Table
Table 1. Characteristics of study participants (n = 470).
Table 1. Characteristics of study participants (n = 470).
VariablesEstimates, n (%)
Age in years, median (IQR)41 (19)
Gender, n (%)
Men358 (76.2)
Women112 (23.8)
Marital status, n (%)
Married230 (49.0)
Not married yet174 (37)
Widow/widower64 (13.6)
No data2 (0.4)
Educational status, n (%)
Low46 (9.8)
Middle195 (41.5)
High226 (48.1)
No data3 (0.6)
Occupation, n (%)
Public servants28 (6.00)
Private sectors409 (87.0)
Not working32 (6.8)
No data1 (0.2)
ART consumption, n (%)
On routine ART453 (96.4) *
Not on ART10 (2.1)
No data7 (1.5)
Recent absolute CD4 count, n (%)
<200 cells/mm354 (11.5)
≥200 cells/mm3343 (72.9)
Unknown73 (15.6)
HIV risk factors, n (%)
Heterosexual86 (18.3)
Homosexual56 (11.9)
Intravenous drug user (IVDU)114 (24.2)
Others20 (4.3)
Not willing to inform70 (14.9)
Unknown124 (26.4)
History of COVID-19 infection, n (%)83 (17.7)
Already recieved the first COVID-19 vaccine, n (%)393 (83.6)
Ever received vaccine other than COVID-19, n (%) **63 (13.4)
*: Median duration of ART consumption = 9 years (IQR 7); **: other than standard mandatory vaccinations during childhood.
Table
Table 2. IBM theoretical constructs and items related to the intention to receive COVID-19 vaccination.
Table 2. IBM theoretical constructs and items related to the intention to receive COVID-19 vaccination.
Construct and Its Associated ItemsCorrected-Item Total CorrelationCronbach’s Alpha
Instrumental attitude 0.910
As long as I take ART regularly, I will be as healthy as a non-HIV individual.0.607
To end the pandemic, I will still follow the health protocols after receiving a COVID-19 vaccination.0.821
Getting the COVID-19 vaccination means I can protect my family.0.780
Getting the COVID-19 vaccination means I can protect myself.0.761
Vaccinating against COVID-19 is one of the efforts to end the pandemic.0.835
Getting the COVID-19 vaccination means I contribute to creating herd immunity.0.832
The COVID-19 vaccination can improve my immunity against COVID-19 infection.0.527
Getting the COVID-19 vaccination will reduce the severity of SARS-CoV−2 infection once I get infected.0.645
Experiential attitude 0.768
I feel more susceptible of getting COVID-19 infection compared to others.0.456
I am worried about receiving the COVID-19 vaccination because it might not be effective in preventing the infection.0.588
I am anxious of the unknown long-term side effects of COVID-19 vaccination.0.598
I am anxious of the side effects of COVID-19 vaccination.0.619
I am afraid of death if I get COVID-19 infection.0.443
Subjective norms 0.918
I receive the COVID-19 vaccine because it is a government program.0.648
My work colleagues expect me to receive the COVID-19 vaccination.0.824
My doctors expect me to receive the COVID-19 vaccination.0.810
My seniors at work expect me to receive the COVID-19 vaccination.0.814
The religious leaders that I respect expect me to receive the COVID-19 vaccination.0.766
My family expects me to receive the COVID-19 vaccination.0.743
Self-efficacy 0.652
In general, how often has the desire to be prioritized in gaining access to health services bothered you?0.507
How often do you feel that your situation is complicated by unclear administration and bureaucracy of health services?0.511
How much does it bother you if you do not pass the COVID-19 health screening?0.378
Perceived behavioral control 0.714
How often have you been in a situation that made it easy for you to achieve what you wanted?0.555
How often does the belief ‘I can do it’ dominate your daily life?0.555
Table
Table 3. Results of regression analysis between the intention to receive the COVID-19 vaccination with constructs of the IBM.
Table 3. Results of regression analysis between the intention to receive the COVID-19 vaccination with constructs of the IBM.
VariablesBβRR2
Instrumental attitude0.006 *0.1270.6590.434
Experiential attitude−0.062−0.030
Subjective norm0.026 **0.497
Self-efficacy−0.67−0.030
Perceived behavioral control0.019 **0.116
*: p < 0.05; **: p < 0.01.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wicaksana, B.; Yunihastuti, E.; Shatri, H.; Pelupessy, D.C.; Koesnoe, S.; Djauzi, S.; Mahdi, H.I.S.; Waluyo, D.A.; Djoerban, Z.; Siddiq, T.H. Predicting Intention to Receive COVID-19 Vaccination in People Living with HIV using an Integrated Behavior Model. Vaccines 2023, 11, 296. https://doi.org/10.3390/vaccines11020296

AMA Style

Wicaksana B, Yunihastuti E, Shatri H, Pelupessy DC, Koesnoe S, Djauzi S, Mahdi HIS, Waluyo DA, Djoerban Z, Siddiq TH. Predicting Intention to Receive COVID-19 Vaccination in People Living with HIV using an Integrated Behavior Model. Vaccines. 2023; 11(2):296. https://doi.org/10.3390/vaccines11020296

Chicago/Turabian Style

Wicaksana, Bramantya, Evy Yunihastuti, Hamzah Shatri, Dicky C. Pelupessy, Sukamto Koesnoe, Samsuridjal Djauzi, Haridana Indah Setiawati Mahdi, Dyah Agustina Waluyo, Zubairi Djoerban, and Tommy Hariman Siddiq. 2023. "Predicting Intention to Receive COVID-19 Vaccination in People Living with HIV using an Integrated Behavior Model" Vaccines 11, no. 2: 296. https://doi.org/10.3390/vaccines11020296

APA Style

Wicaksana, B., Yunihastuti, E., Shatri, H., Pelupessy, D. C., Koesnoe, S., Djauzi, S., Mahdi, H. I. S., Waluyo, D. A., Djoerban, Z., & Siddiq, T. H. (2023). Predicting Intention to Receive COVID-19 Vaccination in People Living with HIV using an Integrated Behavior Model. Vaccines, 11(2), 296. https://doi.org/10.3390/vaccines11020296

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop